TechJournal South
Header

Archive for May, 2010

Andy Jones, formerly with Boulder Ventures, joins High Street

Thursday, May 20th, 2010

highstreetpartners logoANNAPOLIS, MD – Andy Jones, a veteran of Grotech and most recently Boulder Ventures, has joined Annapolis-based High Street Partners as a vice president of corporate strategy.

High Street notes that Jones brings 23 years of successful experience in venture capital, consulting, operations and engineering to the firm.

He is responsible for leading short- and long-term corporate planning, impacting business development and sales, strategic partnerships, fund raising and M&A opportunities.

He also heads the development of HSP’s new customized SaaS application to streamline client operations, scheduled for formal launch later in 2010.

Before joining HSP, Jones spent 13 years in venture capital at Grotech Ventures and then as general partner at Boulder Ventures. Prior to Grotech, Jones was with Andersen Consulting and Deloitte Consulting. He began his career as an engineer at Motorola.

High Street, which raised $6 million in financing earlier this month, sells international business services, providing a single source for the implementation and ongoing management of international subsidiaries and other entities, including registration, payroll, accounting, bookkeeping, tax compliance, advisory and HR localization services.

Vortex Control Technologies lifts off with $2M funding

Thursday, May 20th, 2010

vortex logoSMYRNA, GA – Vortex Control Technologies, a company creating products that reduce drag on aircraft and other vehicles, has raised $2 million of a targeted $2.2 million round of equity financing, according to a regulatory filing.

The company, based in Smyrna, is backed by appropriately named Propeller Investments, which is based in New York but also has an Atlanta office.

The company’s technology improves control and stability features of vehicles, says the Georgia Centers of Innovation.

The Vortex Web site has only a logo.

ComScore Webinar to review U.S. online retail economy

Wednesday, May 19th, 2010

comScoreRESTON, VA – Gian Fulgoni, chairman of comScore, the digital measurement firm, will present a quarterly review of the U.S. online retail economy during a free live Webinar Thursday, May 27, form 2 to 3 p.m. EST.

It includes an overview of e-commerce trends in the first quarter of 2010, survey findings that highlight consumer sentiment about the current state of the economy and a detailed analysis of the social media landscape.

Fulgoni participated in TechJournal South’s first Internet Summit. The next is set for November 17-18.

Presentation highlights include:

  • A recap of early 2010 e-commerce trends, including an analysis of changes in consumers’ online spending patterns from early 2008 through the first quarter of 2010
  • Analysis of spending patterns across key product categories during Q1 2010
  • Review of consumer spending by demographic segments, including gender and household income
  • Comparison of heavy vs. light online shoppers
  • Analysis of key digital marketing trends as they relate to e-commerce, with a particular focus on the social media landscape.

Register here: Online Retail Economy

Biologics raises $800K to buy founders’ shares

Wednesday, May 19th, 2010

biologics-logoCARY, NC – Biologics Inc., a Cary-based cancer management company, has raised just over $800,000 in equity to redeem shares from the company’s founders.

Founded in 1994, the company provides a patient-focused platform for managing the financial, emotional and physical aspects of cancer treatment.

It operates four divisions, Oncology Pharmacy, Oncology Clinical Trial Services, Oncology Management Services for Payors and oncology Biopharmaceutical Solutions.

The company disclosed the funding in a filing with the U.S. Securities and Exchange Commission.

Oncoscope zooms in on nearly $1.5M funding for imaging tech

Wednesday, May 19th, 2010

oncoscope_device

The Oncosocpe Device

DURHAM, NC – Oncoscope, a medical device company that develops proprietary optical imaging systems, has raised  $1.5 million of a mixed equity, debt and securities offering, the company confirms.

Oncoscope was founded in June, 2006 to develop clinical applications of discoveries in the field of optical imaging pioneered by Dr. Adam Wax at the Department of Biomedical Engineering of Duke University. The company raised a $2 million A round and is backed by NC Idea and Southeast TechInventures. It also received a number of SBIR grants, including on for $1 million last year.

These discoveries are known as Angle-resolved Low Coherence Interferometry (a/LCI) and arose from work supported by grants to Duke University from the National Cancer Institute, the National Science Foundation, and the Wallace H. Coulter Foundation.

Oncoscope recently completed its commercial a/LCI system prototype and has commenced clinical testing under a multi-center study sponsored by an SBIR grant from the National Institutes of Health.

Angle-resolved low-coherence interferometry (a/LCI) is a breakthrough biomedical imaging technology which uses the properties of scattered light to measure the average size of cell structures, including cell nuclei. The technology shows promise as a clinical tool for in situ tissue measurements.

The first two clinical sites in this trial are The Center for Esophageal Diseases & Swallowing at the University of North Carolina, Chapel Hill under the direction of Dr. Nicholas J. Shaheen and the Thompson Cancer Survival Center in Knoxville, TN under the direction of Dr. Bergein F. Overholt.

The company disclosed the raise in a filing with the U.S. Securities and Exchange Commission.

Microsoft suing Salesforce.com alleging 9 patent violations

Wednesday, May 19th, 2010

MicrosoftSEATTLE – Microsoft Corp. (Nasdaq: MFST) is suing Salesforce.com, (NYSE: CRM), alleging that the customer relationship management company and software-as-a-service (SaaS) pioneer infringed on nine of its patents.

SEC filings suggest this has been an ongoing battle.

Microsoft says Salesforce.com used its technology in its menu, toolbars, graphic interface and the way it grabs software from remote computers.

Whenever we write about a cloud computing company or one with an SaaS product, they inevitably mention Salesforce.com as a model.

Microsoft actually sells a competing CRM product called Dynamics.

Microsoft filed the suit in federal court in Seattle.

For more details see: Microsoft Corp v Salesforce.com Inc; case number 2:10-cv-00825, in the United States District Court, Western District of Washington at Seattle.

RegeneRx Biopharmaceuticals raising $3.9M in public offering

Wednesday, May 19th, 2010

RegenerexROCKVILLE, MD – RegeneRx Biopharmaceuticals, a company developing drugs to treat people who suffer heart attacks, plans to raise $3.9 million in an underwritten public offering of stock. The move comes on the heels of the company’s $3 million grant from the National Institutes of Health National Heart, Lung and Blood Institute, which we reported earlier this month.

The company has priced 11.5 million shares at 41 cents a share. It will use the proceeds to fund upcoming clinical trials.

RegeneRx is focused on the development of its drug, Tβ4 for tissue and organ protection, repair and regeneration. In published preclinical studies, Tβ4 has been shown to significantly reduce myocardial scar volume, regenerate myocardial tissue, and improve cardiac function after an ischemic event.

While RegeneRx is initially targeting RGN-352 for the treatment of patients who have suffered an acute myocardial infarction, or heart attack, although recent animal research suggests that this formulation may also benefit patients with multiple sclerosis and stroke

The company is planning to initiate a Phase 2 clinical trial with RGN-352 later this year.

CEO Ventures pioneering new model in seed funding

Tuesday, May 18th, 2010

By Allan Maurer

CEO Ventures ribbon cutting

Ribbon cutting at opening of the MAC. That's Mike Price on the far right, Director Dori Linsey on his left.

ATLANTA – Most tech startups fail for one reason: they don’t sell enough. CEO Ventures, an organization of successful CEOs and entrepreneurs that owns and manages a portfolio of tech companies, wants to pioneer a new model for seed stage venture investing with its Market Acceleration Center (MAC).

Michael Price, general partner and original founder of CEO Ventures tells us, “The MAC came out of the harsh reality that seed stage companies struggle with most: getting traction. Building a product has become easier and easier the last few years, but getting traction in a tough environment like we’ve seen the last 24 months is tough. That’s where we have seen the most casualties.”

CEO Ventures, which started out in 1999 as VC South, is a small fund that invests from $100,000 to $300,000 in its portfolio companies.

A startup pitstop

Growing tired of seeing tech startups fail essentially for the same reasons, Price says, “We decided to roll up our sleeves and recognize that while venture capitalists do a great job on screening companies and finding the best technologies where we think there the market is going to be big, ultimately startups tend to die because they can’t get market traction.”

So, Price says, “We thought if that’s how we and most others lose most of our companies, why not put the best minds together to find the best sales practices, customer relationship management systems, and everything else we can think of.” Thus the MAC was born.

The idea, says Price, “Is to act like a NASCAR pitstop. Put the right tires on the car, tune it up, add high octane fuel and give that company a good shove down the race track.”

Clamoring for market traction

To do that, says Price, “We went to some of the best Southeastern companies and talked to CEOs, heads of marketing and sales and we’re sharing their best practices at the center.

Price admits the MAC is an experiment. “We don’t know of any other venture firms doing this, but we have high hopes for it. It’s what our portfolio firms are clamoring for most, ways to get sales and market traction.”

A startup CEO may have all the key characteristics a venture investor looks for yet still may not be “God’s gift to sales,” says Price. “You hope and pray they are,” but that just is not always the case.

“Everyone in our business has historically noticed that even with a B or C-quality product, a highly sales oriented team can usually make the company work. Likewise, even with an A-quality product, a technical team without good sales processes rarely gets to cash flow positive,” Price says.

Will share best practices

So, CEO Ventures is funding the MAC with the intention of teaching its portfolio companies the best ways to sell, sell, sell.

“If you have 10 or 20 firms and get just one or two to perform better, it could have a dramatic impact on your rate of return,” Price says.

It is intended to complement existing seed stage venture models which typically add capital and a slice of an angel or partner’s time, incubators, which include space for equity, and newer models such a YCombinator, which include mentoring. The  MAC will be a more comprehensive model addressing “all common points of failure.”

He says the MAC and CEO Ventures will share its best practices and techniques via white papers and case studies and will publish those on a routine basis.

CEO Ventures already has three firms in the MAC, which launched last week. “The doors are open and part of the initial MAC team has been hired.” In their first two weeks “Dialing and and closing deals” they landed three sales already.

The idea is not to keep portfolio companies in the MAC forever, though. “Once the sales process is cracked, they’ll migrate. We don’t want them to view the venture firm as responsible for generating their revenue.”

Top execs consulted

That could be a problem when a potential buyer did due diligence. “We want them to move through the process,” says Price.

Dori Lindsey is director of the MAC, which will be centrally located at Atlantic Station in Midtown Atlanta.

Executives CEO Ventures consulted to set up the MAC include a who’s who of Atlanta’s tech scene:

Key executives consulted on what  worked in their experiences and on future trends included:

Ron Verni who is the retired CEO of Sage which owns products like ACT!, Peachtree Accounting, etc (and member of CEO Ventures’ Advisory Board), Tom Lynch of Infor (now $2 Billion in revenue), David Cummings of Hannon-Hill and Pardot, Allen Nance of Mansell Group, Glenn McGonnigle of TechOperators, Jim Noble of Noble Systems (member of the Advisory Board), Don Addington of ORTEC, Joe Tibbetts of Sapient who headed a related initiative at Charles River Ventures, Greg Smith of Xerox (member of the Advisory Board), Brooks Robinson who is a Co-Founder of CBeyond, and Tim Mattox who heads Dell’s Worldwide Product Planning (also a member of CEO Ventures’ Advisory Board).

Senate approves financial reform bill amendment on angel investing

Tuesday, May 18th, 2010

U.S. CapitolWASHINGTON, DC – Angel investors seem to have what everyone on Capitol Hill craves these days: bipartisan support. The Senate passed an amendment to the financial reform bill Monday night that keeps requirements for angel investors much as they are now, eliminating changes opposed by venture and technology lobbying organizations.

The amendment, sponsored by Senators Chris Dodd and Kit Bond and co-sponsored by Dems Mark Warner, Maria Cantwell and Mark Begich and Republican Scott Brown, dumps a provision that would have required a 120-review of Angel investor deals.

A PE Hub commentator, in a before and after look at the amendment suggested that the whole fracas over the provision may have just been “political theater,” put in the bill just so legislators could give lobbyists something they wanted by taking it out.

Angel investors also will not have to change how or who they file to on their transactions.

The reform bill does include a “bad actors” provision that goes into effect in a year. It forbids anyone with a criminal record or who ran into trouble with state regulators from being involved in securities offerings for a decade.

“We are very pleased that this amendment was adopted,” said Liddy Karter, chairman of the Angel Capital Association public policy committee and a founder of the Angel Investor Forum of Connecticut. “It ensures that entrepreneurs will more easily be able to raise angel capital and more accredited investors can continue making the angel investments they love to make.”

We’ve covered this story in some depth previously.

See also:

Angel Capital Association resources on federal policy

Venture capitalists, angel investors get hope on financial reform bill changes

Amendments to financial reform bill expected

Interactive Advisory Software adds nearly $2M

Tuesday, May 18th, 2010

IAS logoATLANTA – Interactive Advisory Software (IAS), a company selling a browser-based solution enabling financial advisors to simplify their workload and provide greater service to their clients, has raised nearly $2 million in follow-on financing, according to a regulatory filing.

IAS says its system is built utilizing a consistent, intuitive, visual interface and includes integrated, comprehensive financial planning; portfolio management; client relationship management; rebalancing, client portals and outsourced back office services.

The company raised $1 million in November from Atlanta’s Total Technology Ventures.

The company disclosed this financing in a filing with the U.S. Securities and Exchange Commission.

Merger and Acquistion Roundup, Atlanta, DC, Florida, NC

Tuesday, May 18th, 2010

Harris logoATLANTA, DURHAM, NC, MELBOURNE, FL – Mergers and acquisitions across the Southeast are once again proceeding as if the recession is indeed over.

Harris buying SignaCert

Melbourne-Florida-based Harris Corp., which sells IT and communications services,  says it is acquiring Oregon-based SignaCert, which makes IT compliance software. Financial terms of the deal were not disclosed.

Harris will run the SignaCert business via its DC-based cyber division. SignaCert sells tools that inhibit viruses and malware by only allowing approved software to be used. It raised $8 million in venture backing in 2009 from Arlington-based In-Q-Tel.

CDC Software acquires TradeBeam

Atlanta and Shanghai-based CDC Software Corp. (Nasdaq:CDCS, a hybrid enterprise software provider of on-premise and cloud deployments, has acquired San Mateo, Calif.-based TradeBeam, a provider of on-demand software as a service (SaaS) supply chain visibility and global trade management solutions.

CDC Software and TradeBeam share several common customers, and TradeBeam represents CDC Software’s largest SaaS acquisition to date. This acquisition also represents CDC Software’s latest move in expanding its growing portfolio of cloud-based solutions.

Canon U.S.A. acquires NC-based Tereck Office Solutions

Canon U.S.A. Inc., which sells advanced digital imaging and software solutions, has acquired the assets of Tereck Office Solutions, Inc., based in Durham, North Carolina. It will now be a new, wholly-owned subsidiary of Canon U.S.A. No financial details were disclosed.

The North Carolina-based Tereck is an independent value-added reseller of document imaging and print solutions, including imaging hardware and software, printer fleet and facilities management services.

Qualifying Therapeutic Discovery Project Tax Credit tips

Tuesday, May 18th, 2010

By Lance Hardin, CPA, senior tax manager at Hughes Pittman & Gupton, LLP

HPG logoAs part of the Patient Protection and Affordability Care Act, signed by President Obama on March 23, $1 billion in tax credits and grants are available for qualified therapeutic discovery projects in 2009 and/or 2010.

The addition of the Qualifying Therapeutic Discovery Project Tax Credit was spearheaded Don DeBethizy, Ph.D., CEO of Targacept, a successful biotech company in Winston-Salem, N.C., member of the BIO board and co-chair of its Capital Formation subcommittee.

As the major advocate for the Qualifying Therapeutic Discovery Project Tax Credit, BIO will be offering a webinar with important insights on May 26 at 1 p.m. It will be free to all BIO R&D company members and available to all interested parties. More information can be found at the BIO website.

“It is important for companies to focus on their justification for the tax credit based on ‘unmet need’ and the impact it will have to society,” says Christy Schafer, Ph.D., CEO of Inspire Pharmaceuticals and member of the Emerging Company Section of the BIO board.

Based on the experience gained from the Advanced Energy Manufacturing Credit of 2009, it is anticipated that there may only be a 30-day window in which to prepare and submit an application for the credit or a grant. Businesses need to be ready to drop information into the application, resolve any open items and send in the application within a short timeframe.

Five tips to ease the pressure of a tight deadline are:

1.    Begin data collection now, including budgeting projections and economic impact statistics

2.   Plan to submit a separate applications for each project to be considered

3.    Document the proper number of employees
a.    Consider IRS attribution rules; resolve any related issues
b.    If a partnership or S Corporation, detail of partners in the partnership, including indirect owners through other partners/shareholders

4.    Create detailed project descriptions including
a.    How they qualify
b.    Why you believe the project will be successful

5.   Apply for a DUNS number and register on CCR, Grants.gov and ERA Common

Additionally, there are four tips for application preparation:

1.    Do not provide any reason to deny application:
a.    Use specified format – details matter
b.    Accurate and complete (don’t make reviewer “hunt” for answers)
c.    Adequate and relevant supporting documentation
d.    Clear and concise – consider reader
e.    Consistent message – drive home key points

2.    Demonstrate why you are different from your competition
a.    Differentiate on benefits, costs or jobs
b.    Focus on the five selection criteria
c.    Clearly convey why you expect project success
i.    Prior performance—cite examples
ii.    Analogous situations—cite similar success
d.    Get creative, look for studies by peers or other ways to extrapolate supporting detail for job creation, cost reduction and meeting the other evaluation criteria

3.   Cater to the audience—the government
a.    Highly technical explanations or investor focused wording may detract from your application
b.    Write in layman’s terms
c.    Focus on societal benefits

4.    Expect a quantitative ranking of application regarding job creation, U.S. healthcare cost reduction—provide the data

The key to a successful application will be how well a business differentiates its project from other applications. Engaging outside resources may go a long way toward being successful. Consider accessing industry associations and organizations, as well as experienced tax accounting and grant-writing professionals to help complete and review the application before the deadline.

The views expressed do not necessarily represent Hughes Pittman & Gupton, LLP or Hughes Pittman & Gupton, LLP policy and cannot be relied upon as accounting or tax advice. The outcome of any specific matter depends upon the specific facts and circumstances in which the matter arises. Check with a qualified adviser before taking any action.

Florida-based AxoGen names new CEO

Monday, May 17th, 2010

karenzaderej

Karen Zaderej, new CEO at AxoGen

ALACHUA, FL – AxoGen Inc., a company developing new and more effective products to treat peripheral nerve damage has promoted Karen Zaderej to CEO.

Zaderej was formerly the Chief Operating Officer. Former AxoGen CEO, Jamie Grooms has retained the role of chairman of the Board for AxoGen.

We reported that the company, previously one of TechJournal Souths 50 Companies to watch, raised $3.6 milllion of a financing round targeted at $4.7 million in January. The company previously raised about $20 million from Accuitive Medical Ventures, Cardinal Partners, DeNovo Ventures and Springboard Capital II, SynoGen and the Emergent Growth Fund and with debt financing from Oxford Fiance Corp.

The company says Zaderej has been instrumental in the successful development and launch of the AxoGen portfolio of nerve products for bridging, connecting and protecting peripheral nerves.

Zaderej has more than 20 years of experience in the medical device and tissue markets. At Ethicon, a Johnson & Johnson company, she held senior positions in Marketing, Business Development, and R&D as well as ran a manufacturing business. After leaving J&J, she started Zaderej Medical Consulting to assist medical device companies build and execute winning commercialization plans.

With licensed technologies from the University of Florida, the University of Texas, and Emory University, researchers at AxoGen have developed an innovative technology platform making it possible to process allograft nerves while preserving the relevant characteristics of the three dimensional scaffold of the nerve tissue.

Archiving to the Cloud: A Real-World Example

Monday, May 17th, 2010

Daniel Milburn

Daniel Milburn

By Daniel Milburn

Companies with aggressive growth strategies involving multiple acquisitions are confronted with numerous IT concerns as a result of finalized mergers.

Issues that involve IT infrastructure, data management, and resource consolidation become paramount with quick remedies needed to assure these problems do not negatively impact expansion efforts.

This was exactly the case with KapStone Paper and Packaging Corporation (KapStone) as revenue went from $300M/annually to $1B in just three years. KapStone needed a solution that could accommodate growth trends, reduce storage inefficiencies, improve manageability, lower costs, and provide a roadmap for progress. They found it– in the cloud!

KapStone was able to leverage their existing Enterprise Vault™ investment by choosing Consonus SAFE™ (Secure Archiving for the Enterprise™) to address their IT concerns. A Software-as-a-Service (SaaS) configuration of Symantec Enterprise Vault, SAFE effectively automates the storage, retention, and discovery of unstructured data including email and file systems. Built on a cloud computing infrastructure, data is no longer bound to one physical location or computer.

Without centralized data centers, businesses usually store information on many media, from USB flash drives to laptop hard drives and server clusters. By using SAFE and replicating all data onto a central, efficient data storage infrastructure, costs are reduced, management is simplified, and risk is minimized.

KapStone realized all these benefits and more, including:

  • An 86% file size reduction in just two weeks
  • Reduction in backup time
  • Projected initial ROI within four months
  • An estimated 280% ROI within three years
  • Ability to immediately reclaim existing storage
  • Elimination of outsourced storage costs
  • Reduced administrative burden
  • An improvement in overall, system performance
  • Reduced archive footprint to improve total cost of ownership

Consonus SAFE was able to deliver on the promise of a secure, reliable, and resilient cloud-based solution for file and email archiving. KapStone was so pleased with the results that they are currently reviewing additional strategic solutions that leverage virtualized data storage and management strategies to further improve cost reductions, increase productivity, operational flexibility and responsiveness.

To find out more about SAFE, virtualization technology, and cloud-based solutions provided by Consonus, visits us on the Web at www.Consonus.com.

Sponsored by:

Consonsus logo

Mage Solar bringing U.S. HQ to Georgia, creating 350 jobs

Monday, May 17th, 2010

MagesolarDUBLIN, GA – German firm Mage Solar plans to locate its U.S. headquarters and first manufacturing facility in Dublin, GA. The firm says it will create 350 jobs over five years and invest $30 million in the facilities.

The company garnered almost $7 million in government incentives to spur the move.

The facility will include a training center and solar module manufacturing plant.

The company says Dublin’s strategic location, about half ways between one of the most well-connected airports in the world and the ever expanding Port of Savannah provides the solar company a logistic advantage.

The company also cited Georgia’s workforce training program Quick Start as well as its overall business-oriented climate as making Georgia an attractive state for locating corporate headquarters and manufacturing facilities. In addition, Georgia is also home to the Center of Excellence for Photovoltaics Research and Education at Georgia Tech in Atlanta. Known for its groundbreaking research in clean, renewable energy sources, it is only one out of two centers of its kind nationwide.

The company expects to start production by the end of the year.

Georgia-based MDatacor chalks up $2.6M

Monday, May 17th, 2010

MdatacorALPHARETTA, GA – MDatacor, a company selling software to support health information exchange between doctors and patients, has raised $2.6 million, according to a regulatory filing.

The company says the ability of its platform to extract clinical data from transcription notes, and combine it with claims, pharmacy and clinical data from registries, electronic medical records, practice management and labs systems means it provides the most complete patient data set in the industry.

The company raised $3 million from private investors and strategic partner DIANON Systems Inc. in 2002.

MDatacor says its product is used by more than 7,000 doctors to serve more than seven million patients.

Q-Care more than halfway to $4.5M raise for needle disposal tech

Monday, May 17th, 2010

Q-Care product

A Q-Care unit

MARIETTA, GA – Q Care International. a company that sells a portable device for disposing of used hypodermic needles, has raised $2.64 million of a $4.5 million in equity, according to a regulatory filing.

The company’s U.S. Food and Drug Administration-approved solution renders a used hypodermic syringe harmless.

Using low voltage direct current from nicad batteries, the company’s product melts a small portion of a stainless steel needle, severing it from the syringe. The 2,450 degrees F generated sterilizes the entire syringe.

We have noticed a spate of medical device financing activity in recent months. The sector has been hot for several years now, but as the recession ends, we’re seeing investment dollars flow toward such things as glucose monitors for diabetics and a variety of other medical device products.

The company disclosed the raise in a filing with the U.S. Securities and Exchange Commission.

Telcare rings ups $2.5M of targeted $4M raise for gluscose monitor

Monday, May 17th, 2010

TelcareBETHESDA, MD – Telcare, a company connecting chronically ill patients with their doctors via wireless, has raised $2.5 million of a targeted $4 million equity offering, according to a regulatory filing.

It is the second Maryland company developing a glucose testing product for diabetics that has raised financing this month. We reported a $10 million raise by Germantown-based Sensors for Medicine and Science just last week.

Founded in 2008, Telcare is developing a glucose meter for diabetics due for release in the second quarter 2010,  that sends test results to a care management server and provides instant feedback and coaching to the patient.

The TELCARE blood glucose meter platform is based on an already FDA-cleared glucose meter platform that meets the latest standard of accuracy and offers auto-coding test strips, ultra-low sample volume, and alternate site testing.

The global market for glucose meters and strips is targeted at the more than 20 million Americans with diabetes with an $8 billion market size.

Telcare says Home glucose monitoring is universally recognized as essential to the management of diabetes and prevention of complications. A one unit reduction in A1c, the gold standard for glucose control is proven to result in a 37 percent reduction in complications and costs of care.

The company’s product has not yet been cleared by the U.S. Food and Drug Administration for sale.

The company disclosed the raise in a filing with the U.S. Securities and Exchange Commission.

ITT Corp. expanding in Columbia, adding 100 jobs

Friday, May 14th, 2010

ITT corpCOLUMBIA, MD – ITT Corp. is expanding its Advanced Information Systems division at the Columbia Gateway Business Park and will create more than 100 new jobs.

The company is adding 28,000 additonal square feet to its current space in the business park.

The division develops hardware and software and cybersecurity for the U.S. government, law enforcement and commercial clients.

The move is partly due to Defense Department initiatives such as BRAC (Base Realignment and Closure) which is expected to add thousands of jobs in the region over the next few years.

ITT, headquartered in White Plains, NY, also has a offices in McLean, VA.

River Cities Capital Funds sees string of SaaS successes

Friday, May 14th, 2010

By Allan Maurer

Rik Vandevenne

Rik Vandevenne

RALEIGH, NC – River Cities Capital Funds has had a string of successful exits among its Software-as-a-Service (SaaS) portfolio companies recently and may soon have another—Cary, NC-based SciQuest, which is lined up to launch an initial public offering of stock.

Raleigh-based River Cities Principal Rik Vandevenne tells us that the firm invested in eight SaaS companies, “primarily in the 2002-2007 timeframe before people really understood the power of the SaaS model.”

SPS Commerce, a St. Paul, Minnesota-based SaaS supply-chain software company, launched a successful IPO April 22 and became the only one of a busy day to trade above its $12 IPO price, opening at $14 on the Nasdaq exchange.

SPS Commerce marks the third successful SaaS portfolio exit for River Cities in the recent past.  In 2007 California-based EVault was sold to Seagate for $185 million as the foundation of their managed data protection services offering, i365. In 2009 McAfee acquired Denver-based MX Logic for $170 million to add hosted email filtering to its “Security as a Service” solution.

Vandevenne points out that such success stories are important because the venture industry is shrinking and funds will have to show good returns to keep investing in high growth companies. He adds, “We think there is an appetite in the public markets for high growth tech companies.”

Actively looking for deals

River Cities, which also has an office in Cinncinnati, Ohio, has been investing in Midwest and Southeast startups for 25 years and has had a Raleigh office for ten, Vandevenne says. “We’re actively investing and looking to make investments,” he adds.

Vandevenne joined Ed McCarthy at the Raleigh office in 2004

“We are investing out of our fourth fund, $120 million, that we raised in 2008. We primarily invest in the Midwest and Southeast which we believe are underserved venture territories and look to partner with visionary entrepreneurs to grow market leading companies.”

Vandevenne says that means “You may have to turn over more stones to find the gems, but not all the gold is in California.”

“We invest in healthcare and information technology companies that are beyond the concept stage and have meaningful revenues and customers that validate the model.

Prepared for follow-on investments

“In healthcare we invest in medical devices, healthcare Services and healthcare IT.” He says that in medical device companies, River Cities looks for those useful to “the average doctor, not just the super specialized surgeon with magic hands,” and where there is a clear path to reimbursement and the money it invests will go primarily to sales and marketing.

“On the information technology side we look for SaaS, Cloud, enterprise software and technology enabled business services.”

Vandevenne says the firm typically invests from $3 million to $6 million initially, but “always reserve significant capital for further investment as things often take longer than one expects.”

He says River Cities is looking for visionary entrepreneurs with a proven model that has revenue of about $2 million annually.

Portfolio companies hiring

We hope some lawmakers in DC are reading this. As more evidence that startup firms and the venture industry are the real job creation engines in the United States, Vandevenne says there are 55 portfolio company jobs listed on River Cities Web site and “That’s only a fraction of the jobs they have open.”

That’s in line with our earlier story noting that many portfolio companies of other regional venture firms also have numerous job openings.

In addition to SciQuest–which Vandevenne could not discuss since it is lined up for an IPO–the firm’s Southeast portfolio companies include Prenova, Afterbot, and Prosero, and EndoChoice,  in Atlanta, Privaris, Charlottesville, VA, High Speed Access in Louisville, KY, and Convey Systems in Charlotte.